{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:32:28Z","timestamp":1777332748588,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013094","name":"Science and Technology Planning Social Development Project of Zhenjiang City","doi-asserted-by":"publisher","award":["SH2024067"],"award-info":[{"award-number":["SH2024067"]}],"id":[{"id":"10.13039\/501100013094","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013094","name":"Science and Technology Planning Social Development Project of Zhenjiang City","doi-asserted-by":"publisher","award":["SH2025033"],"award-info":[{"award-number":["SH2025033"]}],"id":[{"id":"10.13039\/501100013094","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Provincial Medical Key Discipline Cultivation Unit","award":["JSDW202241"],"award-info":[{"award-number":["JSDW202241"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44419-2","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T16:45:11Z","timestamp":1773506711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long noncoding RNA FOXP1-DT modulates regulatory T cells in Graves\u2019 disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Qian","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanbin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianfang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"44419_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S2213-8587(23)00005-0","volume":"11","author":"WM Wiersinga","year":"2023","unstructured":"Wiersinga, W. M., Poppe, K. G. & Effraimidis, G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. Lancet Diabetes Endocrinol. 11, 282\u2013298 (2023).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"44419_CR2","doi-asserted-by":"crossref","unstructured":"Lee, S. Y. & Pearce, E. N.  Hyperthyroidism. Rev. JAMA 330, 1472\u20131483 (2023).","DOI":"10.1001\/jama.2023.19052"},{"key":"44419_CR3","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1210\/endrev\/bnaa022","volume":"41","author":"LC Lane","year":"2020","unstructured":"Lane, L. C., Cheetham, T. D., Perros, P. & Pearce, S. H. S. New therapeutic horizons for Graves\u2019 hyperthyroidism. Endocr. Rev. 41, 873\u2013884 (2020).","journal-title":"Endocr. Rev."},{"key":"44419_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41574-024-01016-5","volume":"20","author":"G Lanzolla","year":"2024","unstructured":"Lanzolla, G., Marino, M. & Menconi, F. Graves disease: latest understanding of pathogenesis and treatment options. Nat. Rev. Endocrinol. 20, 647\u2013660 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"key":"44419_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41580-023-00694-9","volume":"25","author":"J Ferrer","year":"2024","unstructured":"Ferrer, J. & Dimitrova, N. Transcription regulation by long non-coding RNAs: mechanisms and disease relevance. Nat. Rev. Mol. Cell. Biol. 25, 396\u2013415 (2024).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"44419_CR6","doi-asserted-by":"publisher","first-page":"e2300063","DOI":"10.1002\/advs.202300063","volume":"10","author":"I Gonz\u00e1lez-Moro","year":"2023","unstructured":"Gonz\u00e1lez-Moro, I. et al. LncRNA ARGI contributes to virus-induced pancreatic \u03b2 cell inflammation through transcriptional activation of IFN-stimulated genes. Adv. Sci. (Weinh)  10, e2300063 (2023).","journal-title":"Adv. Sci. (Weinh)"},{"key":"44419_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.semcancer.2020.07.003","volume":"83","author":"AQ Khan","year":"2022","unstructured":"Khan, A. Q. et al. Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseases. Semin. Cancer Biol. 83, 208\u2013226 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"44419_CR8","doi-asserted-by":"publisher","first-page":"106549","DOI":"10.1016\/j.phrs.2022.106549","volume":"186","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. The role of non-coding RNAs (miRNA and lncRNA) in the clinical management of rheumatoid arthritis. Pharmacol. Res. 186, 106549 (2022).","journal-title":"Pharmacol. Res."},{"key":"44419_CR9","doi-asserted-by":"crossref","unstructured":"Liu, Y. et al. Comprehensive analysis of lncRNA expression profile and the potential role of ENST00000604491 in Graves\u2019 disease. J. Immunol. Res. 2022, 8067464 (2022).","DOI":"10.1155\/2022\/8067464"},{"key":"44419_CR10","doi-asserted-by":"crossref","unstructured":"Dong, D. et al. Normal Treg homeostasis and suppressive function require both FOXP1 and FOXP4. JCI Insight 10, 8596 (2025).","DOI":"10.1172\/jci.insight.195981"},{"key":"44419_CR11","doi-asserted-by":"publisher","first-page":"971045","DOI":"10.3389\/fimmu.2022.971045","volume":"13","author":"Y Kaminskiy","year":"2022","unstructured":"Kaminskiy, Y., Kuznetsova, V., Kudriaeva, A., Zmievskaya, E. & Bulatov, E. Neglected, yet significant role of FOXP1 in T-cell quiescence, differentiation and exhaustion. Front. Immunol. 13, 971045 (2022).","journal-title":"Front. Immunol."},{"key":"44419_CR12","doi-asserted-by":"publisher","first-page":"632492","DOI":"10.3389\/fendo.2021.632492","volume":"12","author":"Z Chen","year":"2021","unstructured":"Chen, Z. et al. Decreased Treg cell and TCR expansion are involved in long-lasting Graves\u2019 disease. Front. Endocrinol. (Lausanne). 12, 632492 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"44419_CR13","doi-asserted-by":"crossref","unstructured":"Kustrimovic, N. et al. Regulatory T cells in the pathogenesis of Graves\u2019 disease. Int. J. Mol. Sci. 24, 968 (2023).","DOI":"10.3390\/ijms242216432"},{"key":"44419_CR14","doi-asserted-by":"publisher","first-page":"155818","DOI":"10.1016\/j.phymed.2024.155818","volume":"132","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Mechanism of Prunella vulgaris L. and luteolin in restoring Tfh\/Tfr balance and alleviating oxidative stress in Graves\u2019 disease. Phytomedicine 132, 155818 (2024).","journal-title":"Phytomedicine"},{"key":"44419_CR15","doi-asserted-by":"publisher","first-page":"572","DOI":"10.5603\/EP.a2021.0076","volume":"72","author":"S Janyga","year":"2021","unstructured":"Janyga, S. et al. CD4\u2009+\u2009cells in autoimmune thyroid disease. Endokrynol. Pol. 72, 572\u2013583 (2021).","journal-title":"Endokrynol. Pol."},{"key":"44419_CR16","doi-asserted-by":"publisher","first-page":"e70253","DOI":"10.1002\/ctm2.70253","volume":"15","author":"X Xia","year":"2025","unstructured":"Xia, X., Wu, H., Chen, Y., Peng, H. & Wang, S. Ferroptosis of T cell in inflammation and tumour immunity. Clin. Transl. Med. 15, e70253 (2025).","journal-title":"Clin. Transl. Med."},{"key":"44419_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","volume":"24","author":"TS Sumida","year":"2024","unstructured":"Sumida, T. S., Cheru, N. T. & Hafler, D. A. The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases. Nat. Rev. Immunol. 24, 503\u2013517 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"44419_CR18","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12020-023-03490-9","volume":"83","author":"S Zhao","year":"2024","unstructured":"Zhao, S. et al. A role of NR4A2 in Graves\u2019 disease: regulation of Th17\/Treg. Endocrine 83, 432\u2013441 (2024).","journal-title":"Endocrine"},{"key":"44419_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.molimm.2022.02.004","volume":"144","author":"HY Liu","year":"2022","unstructured":"Liu, H. Y. et al. Absolute reduction in peripheral regulatory T cells in patients with Graves\u2019 disease and post-treatment recovery. Mol. Immunol. 144, 49\u201357 (2022).","journal-title":"Mol. Immunol."},{"key":"44419_CR20","doi-asserted-by":"publisher","first-page":"102502","DOI":"10.1016\/j.tice.2024.102502","volume":"90","author":"H Cai","year":"2024","unstructured":"Cai, H., Chen, S., Jiang, Z., Chen, L. & Yang, X. PTPN22 through the regulation of Th17\/Treg balance acts as a potential target for the treatment of Graves\u2019 disease. Tissue Cell. 90, 102502 (2024).","journal-title":"Tissue Cell."},{"key":"44419_CR21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41580-023-00694-9","volume":"25","author":"J Ferrer","year":"2024","unstructured":"Ferrer, J. & Dimitrova, N. Transcription regulation by long non-coding RNAs: mechanisms and disease relevance. Nat. Rev. Mol. Cell. Biol. 25, 396\u2013420 (2024).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"44419_CR22","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","volume":"82","author":"AB Herman","year":"2022","unstructured":"Herman, A. B., Tsitsipatis, D. & Gorospe, M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol. Cell. 82, 2252\u20132266 (2022).","journal-title":"Mol. Cell."},{"key":"44419_CR23","doi-asserted-by":"crossref","unstructured":"Bridges, M. C., Daulagala, A. C. & Kourtidis, A. LNCcation: lncRNA localization and function. J. Cell. Biol. 220, 2563  (2021).","DOI":"10.1083\/jcb.202009045"},{"key":"44419_CR24","doi-asserted-by":"publisher","first-page":"e3000270","DOI":"10.1371\/journal.pbio.3000270","volume":"17","author":"J Ren","year":"2019","unstructured":"Ren, J. et al. Foxp1 is critical for the maintenance of regulatory T-cell homeostasis and suppressive function. PLoS Biol. 17, e3000270 (2019).","journal-title":"PLoS Biol."},{"key":"44419_CR25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41590-018-0291-z","volume":"20","author":"C Konopacki","year":"2019","unstructured":"Konopacki, C., Pritykin, Y., Rubtsov, Y., Leslie, C. S. & Rudensky, A. Y. Transcription factor Foxp1 regulates Foxp3 chromatin binding and coordinates regulatory T cell function. Nat. Immunol. 20, 232\u2013242 (2019).","journal-title":"Nat. Immunol."},{"key":"44419_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41590-023-01685-w","volume":"25","author":"Z Zhu","year":"2024","unstructured":"Zhu, Z. et al. FOXP1 and KLF2 reciprocally regulate checkpoints of stem-like to effector transition in CAR T cells. Nat. Immunol. 25, 117\u2013128 (2024).","journal-title":"Nat. Immunol."},{"key":"44419_CR27","doi-asserted-by":"publisher","first-page":"e15712","DOI":"10.1002\/advs.202415712","volume":"12","author":"L Niu","year":"2025","unstructured":"Niu, L. et al. Engineered Foxp1(high) exosomes ameliorates systemic lupus erythematosus. Adv. Sci. (Weinh). 12, e15712 (2025).","journal-title":"Adv. Sci. (Weinh)"},{"key":"44419_CR28","doi-asserted-by":"crossref","unstructured":"Vargas-Uricoechea, H., Nogueira, J. P., Pinz\u00f3n-Fern\u00e1ndez, M. V. & Schwarzstein, D. The usefulness of thyroid antibodies in the diagnostic approach to autoimmune thyroid disease. Antibodies (Basel) 12, 2563 (2023).","DOI":"10.20944\/preprints202306.1623.v1"},{"key":"44419_CR29","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1210\/clinem\/dgae222","volume":"109","author":"D Villagelin","year":"2024","unstructured":"Villagelin, D., Cooper, D. S. & Burch, H. B. A 2023 international survey of clinical practice patterns in the management of Graves disease: a decade of change. J. Clin. Endocrinol. Metab. 109, 2956\u20132966 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"44419_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s42000-023-00437-7","volume":"22","author":"M Katahira","year":"2023","unstructured":"Katahira, M. et al. Clinical significance of thyroglobulin antibodies and thyroid peroxidase antibodies in Graves\u2019 disease: a cross-sectional study. Horm. (Athens). 22, 253\u2013261 (2023).","journal-title":"Horm. (Athens)"},{"key":"44419_CR31","doi-asserted-by":"publisher","first-page":"119700","DOI":"10.1016\/j.cca.2024.119700","volume":"559","author":"Y Gao","year":"2024","unstructured":"Gao, Y., Qiu, L., Yu, S. & Cheng, X. Thyroid stimulating receptor autoantibodies. Clin. Chim. Acta  559, 119700 (2024).","journal-title":"Clin. Chim. Acta"},{"key":"44419_CR32","doi-asserted-by":"publisher","first-page":"110989","DOI":"10.1016\/j.clinbiochem.2025.110989","volume":"139","author":"Z Jiang","year":"2025","unstructured":"Jiang, Z. et al. Diagnostic value of serum TSI levels in Graves\u2019 disease and direct comparison of diagnostic performance with TRAb: a systematic review and meta-analysis. Clin. Biochem. 139, 110989 (2025).","journal-title":"Clin. Biochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44419-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44419-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44419-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:36:15Z","timestamp":1777329375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44419-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44419"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44419-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"25 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13539"}}